Abbott Laboratories (ABT)

September 3rd, 2020


Stay up to date

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Financial Statements

Key Info

  • Industry: Medical Specialties
  • Sector: Health Technology
  • CEO Name: Robert B. Ford

Key Statistics

  • Stock Price: $109.44
  • Dividend Yield: 1.3%
  • Market Capitalization: $193,766,803,200
  • Shares Outstanding: 1,770,530,000
  • Number of Employees: 107,000
  • Trailing 12-Month EPS: $1.75
  • Trailing 12-Month DPS: $1.4
  • Payout Ratio: 80.0%

Important Dates

  • Next Earnings Date: 2020-10-14
  • Next Ex-Dividend Date: 2020-07-14

Price Trends

  • Current Stock Price: $109.44
  • 52-week high: $114.2
  • 52-week low: $61.61
  • 200-day moving average: $89.67
  • 50-day moving average: $98.88


  • 1-Month Price Return: 8.7%
  • 3-Month Price Return: 19.7%
  • 6-Month Price Return: 40.3%
  • 1-Year Price Return: 30.2%
  • 2-Year Price Return: 63.8%
  • 5-Year Price Return: 141.7%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

September 3rd, 2020